The review discusses 58 peptides in different clinical phases, indicating a robust pipeline of peptide therapies focusing on PPIs. By these clinical trials, researchers are not merely uncovering new treatment plans but will also be paving the way for personalized medicine, where therapies may be personalized to the person's one https://friedrichg616xhq2.gynoblog.com/profile